bioAffinity Technologies Inc (BIAFW) Stock Price & News

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	1.59M	1.35M	1.51M	-
Cost of goods sold	900.13K	928.64K	1.09M	-
Cost of revenue	900.13K	928.64K	1.09M	-
Research and development expenses	668.81K	683.75K	837.46K	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.04M	3.24M	2.86M	-
Operating expense	3.83M	4.04M	3.76M	-
Total operating expenses	4.73M	4.97M	4.85M	-
Operating income	-3.14M	-3.62M	-3.33M	-
Other non operating income	-3.98K	-8.94K	-22.89K	-
EBT including unusual items	-3.13M	-3.63M	-3.37M	-
EBT excluding unusual items	-3.13M	-3.63M	-3.37M	-
Income tax expense	3.18K	-	-	-
Effective tax rate	-0.10%	-	-	-
Other operating expenses	-	-	-	-
Net income	-3.14M	-3.63M	-3.37M	-
Net profit margin	-196.98%	-268.63%	-222.83%	-
Earnings per share	-	-	-	-
Interest and investment income	19.73K	10.03K	3.36K	-
Interest expense	-13.07K	-14.72K	-11.69K	-
Net interest expenses	6.66K	-4.70K	-8.33K	-
Depreciation and amortization charges	123.66K	114.52K	61.56K	-
EBITDA	-3.01M	-3.50M	-3.27M	-
Gain or loss from assets sale	-	-	-	-

Finance